Weathering the storm together
It was a night to celebrate: MBI founder Fernando Goldsztein had the honor of stepping on stage together with MBI partner and medulloblastoma survivor Daniel Scola.
A (lemonade) toast to Ava and friends
Supported by her family and hard-working friends, Ava Strong, a kid with brain cancer, sold enough lemonade to raise U$ 225 for medulloblastoma research...
MATCHPOINT: Has Medulloblastoma Met Its Match?
Duane Mitchell, MD, PhD, co-director of the University of Florida’s Preston A. Wells Jr. Center for Brain Tumor Therapy, leads the MATCHPOINT trial. The therapy harnesses adoptive cell therapy (ACT), which...
CLINICAL TRIALS APPROVED!
Drs. Duane Mitchell and Elias Sayour from the Cure Group 4 Consortium have received approval from the Food and Drug Administration to test...
You are invited to the Race for Every Child
It's a real race in Washington, D.C., but you can participate from anywhere in the world—speeding up efforts to raise funds for child research and care...
A milestone for MBI
Scientists, academics, researchers, entrepreneurs, and media personalities gathered last Wednesday (May 10th) at the Brazilian Embassy in Washington, D.C...
To save a life: Lessons for launching a medical R&D initiative
In February 2024, MBI was featured eJewish Philanthropy, a news publication covering the world of Jewish philanthropy. The platform engages in daily discussions via original reporting...
The quest for a cure for medulloblastoma
Em março de 2024, a Revista PUCRS publicou a bela a entrevista concedida pelo alumnus Fernando Goldsztein, Fundador da The Medulloblastoma Initiative e Conselheiro da Children’s National Hospital Foundation…
MBI at the largest scientific event in neuro-oncology in Latin America
Last saturday (23), MBI founder Fernando Goldsztein participated in the Present-Future session of Snola 2024, the largest scientific event in neuro-oncology in Latin America...
A big step for MBI
On March 6th, wednesday, the story of The Medulloblastoma Initiative (MBI) was presented to the Permanent Council of the OAS (Organization of American States @oea_oficial ) in Washington D.C., during the session dedicated to World Rare Disease Day.
